S353 Time to Clinically Meaningful Improvement in Dysphagia Frequency in Adults with Eosinophilic Esophagitis: A Post-Hoc Analysis From a Phase 2b Trial of APT-1011, a Fluticasone Propionate Oral Disintegrating Tablet

Authors :: Gary W. Falk
Gail M. Comer
Karol Knoop
Alfredo J. Lucendo
Evan S. Dellon
Ikuo Hirano
Christop Schlag
James Nezamis
Gina Eagle
Alain M. Schoepfer
Source :: American Journal of Gastroenterology. 116:S152-S153
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
medicine.disease
Dysphagia
Fluticasone propionate
Internal medicine
Post-hoc analysis
medicine
medicine.symptom
Eosinophilic esophagitis
business
medicine.drug

Full Text Access

Tools